找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cancer Immunology; Bench to Bedside Imm Nima Rezaei Book 20151st edition Springer-Verlag Berlin Heidelberg 2015 Cancer immunology.Cancer im

[复制链接]
楼主: Coarse
发表于 2025-3-28 16:55:42 | 显示全部楼层
f cancers, with a focus on clinical aspects.Describes in depThis translational book describes in detail the clinical application of novel approaches in cancer immunotherapy with the aim of educating clinicians in the implications of the most recent research and new developments in the field. The sco
发表于 2025-3-28 20:50:49 | 显示全部楼层
发表于 2025-3-29 01:23:19 | 显示全部楼层
发表于 2025-3-29 05:30:39 | 显示全部楼层
发表于 2025-3-29 10:44:54 | 显示全部楼层
Monoclonal Antibodies for Cancer Immunotherapy,rapeutic mAbs entails gaining in-depth knowledge about factors including antibody structure and function, the properties of an ideal tumor antigen, the advantages of employing combinational therapies, and the limitations of antibody-based modalities. This chapter concentrates on mAbs as versatile platforms for cancer immunotherapy.
发表于 2025-3-29 12:18:04 | 显示全部楼层
Book 20151st editionin the implications of the most recent research and new developments in the field. The scope is broad, encompassing, for example, prognostic biomarkers for personalized cancer treatment, strategies for targeting tumor immunosuppression, gene therapy, virus-based vaccines, targeting of cancer stem ce
发表于 2025-3-29 19:07:26 | 显示全部楼层
Ger J. van der Vusse,Robert S. Renemantherapeutic options to a broad range of malignancies. This chapter will review the rationale for targeting immune checkpoints, the pathways of particular interest, and the research being conducted to bring checkpoint blockade to clinical use.
发表于 2025-3-29 23:34:33 | 显示全部楼层
发表于 2025-3-29 23:58:50 | 显示全部楼层
Overcoming Cancer Tolerance with Immune Checkpoint Blockade,therapeutic options to a broad range of malignancies. This chapter will review the rationale for targeting immune checkpoints, the pathways of particular interest, and the research being conducted to bring checkpoint blockade to clinical use.
发表于 2025-3-30 05:42:10 | 显示全部楼层
Toll-Like Receptor Pathway and its Targeting in Treatment of Cancers,e TLR function varies according to the cancer type and the TLRs expressed, their signaling pathway should either be triggered or targeted to control cancer progression. Hence, more investigations are required to discover proper therapeutic approaches for cancer.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-26 15:07
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表